| Q33354156 | Arterially perfused neurosphere-derived cells distribute outside the ischemic core in a model of transient focal ischemia and reperfusion in vitro |
| Q37952704 | Behavioral outcome measures used for human neural stem cell transplantation in rat stroke models |
| Q26866330 | Brain repair: cell therapy in stroke |
| Q36996270 | Cell tracing techniques in stem cell transplantation |
| Q63966766 | Combined Therapeutic Strategy Using Erythropoietin and Mesenchymal Stem Cells Potentiates Neurogenesis after Transient Focal Cerebral Ischemia in Rats |
| Q34306382 | Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats |
| Q88658969 | Effect of Combination Therapy with Neuroprotective and Vasoprotective Agents on Cerebral Ischemia |
| Q48306105 | Effects of cerebral microvascular endothelial cells and vascular endothelial growth factor on the proliferation and differentiation of NSCs: a comparative study |
| Q38020128 | Effects of vascular endothelial growth factor in ischemic stroke |
| Q47141294 | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application |
| Q48241119 | Engrafting fetal liver cells into multiple tissues of healthy adult mice without the use of immunosuppressants. |
| Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
| Q35216143 | Growth factors in ischemic stroke. |
| Q33614725 | Human nerual stem cells for brain repair |
| Q39659177 | Human neural stem cells genetically modified to overexpress brain‐derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model |
| Q37876358 | Hypoxia in the regulation of neural stem cells |
| Q37572370 | Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. |
| Q48612634 | Intravenously Infused F3.Olig2 Improves Memory Deficits via Restoring Myelination in the Aged Hippocampus Following Experimental Ischemic Stroke |
| Q26773165 | Mechanisms and Functional Significance of Stroke-Induced Neurogenesis |
| Q39137284 | Neural stem cell-based gene therapy for brain tumors |
| Q57460363 | Regenerative Strategies for the Central Nervous System |
| Q38742380 | Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke |
| Q41928171 | Stem cell-based therapies for ischemic stroke |
| Q37519562 | Systemic neurotransplantation--a problem-oriented systematic review |
| Q48490657 | The experimental therapy on brain ischemia by improvement of local angiogenesis with tissue engineering in the mouse |
| Q41605851 | The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats |
| Q38099747 | Therapeutic applications of bone marrow-derived stem cells in ischemic stroke |
| Q44045737 | Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats. |
| Q33699018 | Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats |
| Q44194545 | VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function |
| Q37862156 | Vascular endothelial growth factor in cerebral ischemia |
| Q26853592 | Vascular endothelial growth factors (VEGFs) and stroke |